The transaction is expected to close in the first quarter of 2008, subject to required government approvals. Financial terms have not been disclosed.
Sr Jose Martin, spokesperson for Werfen, said: “Inova’s research pipeline and scientific expertise is complementary to Werfen’s in vitro test and instrumentation product line. We are excited by the growth prospects for this segment of the medical diagnostic industry and we are ready to assist Inova in realizing its growth plans. We expect to keep Inova’s research, manufacturing and administrative operations in San Diego and expand them as necessary in that area.”